LSD1 negatively regulates the expression of tumor suppressor gene SIRT3 in pancreatic cancer cell line PANC-1

徐近; 秦毅; 张波; 吉顺荣; 许文彦; 施思; 刘江; 虞先濬

doi:10.3969/j.issn.1007-3969.2014.02.002

您当前的位置：

首页 >

文章列表页 >

LSD1 negatively regulates the expression of tumor suppressor gene SIRT3 in pancreatic cancer cell line PANC-1

更新时间：2025-12-31

- LSD1 negatively regulates the expression of tumor suppressor gene SIRT3 in pancreatic cancer cell line PANC-1
- China Oncology Vol. 24, Issue 2, Pages: 87-92(2014)
- 作者机构：
  
  复旦大学附属肿瘤医院胰腺肝胆外科，复旦大学上海医学院肿瘤学系，胰腺肿瘤研究所,上海,200032
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.1007-3969.2014.02.002
  CLC：
- Published Online：07 March 2014，
  
  Published：07 March 2014
- 稿件说明：
移动端阅览
徐近,秦毅,张波,吉顺荣,许文彦,施思,刘江,虞先濬. 胰腺癌细胞PANC-1中LSD1负向调控抑癌基因SIRT3的实验研究[J]. 中国癌症杂志, 2014, 24(2): 87-92.

徐近, 秦毅, 张波, et al. LSD1 negatively regulates the expression of tumor suppressor gene SIRT3 in pancreatic cancer cell line PANC-1[J]. China Oncology, 2014, 24(2): 87-92.
徐近,秦毅,张波,吉顺荣,许文彦,施思,刘江,虞先濬. 胰腺癌细胞PANC-1中LSD1负向调控抑癌基因SIRT3的实验研究[J]. 中国癌症杂志, 2014, 24(2): 87-92. DOI： 10.3969/j.issn.1007-3969.2014.02.002.

徐近, 秦毅, 张波, et al. LSD1 negatively regulates the expression of tumor suppressor gene SIRT3 in pancreatic cancer cell line PANC-1[J]. China Oncology, 2014, 24(2): 87-92. DOI： 10.3969/j.issn.1007-3969.2014.02.002.

摘要

背景与目的：组蛋白赖氨酸去甲基化酶1(lysine specific demethylase 1，LSD1)是重要的染色质修饰蛋白之一，可以通过调节染色质的结构调节基因的转录调控，进而影响肿瘤的发生、发展、侵袭、转移以及代谢异常等恶性潜能，是判断肿瘤预后的生物标志物。Sirtuins家族去乙酰化酶3(sirtuin3，SIRT3)基因是位于线粒体内的抑癌基因，通过调控肿瘤代谢异常以及氧化损伤行使抑癌基因的功能。本研究通过基因转录调控的手段，研究胰腺癌细胞PANC-1中LSD1与SIRT3的关系。方法：通过RNA干扰(RAN interference，RNAi)、免疫共沉淀(co-immunoprecipitation，CoIP)、染色质免疫共沉淀(chromatin immunoprecipitationassay，ChIP)及启动子活性分析等分子生物学实验手段，探讨LSD1与SIRT3在PANC-1细胞中的关系。结果：通过RNAi的手段干扰LSD1的表达，发现SIRT3基因转录水平和蛋白水平明显上升；通过蛋白相互作用的手段，发现LSD1可以与SIRT3转录调控的重要转录因子过氧化物酶增殖体激活受体辅激动子-1α(peroxisomeproliferator-activated receptor gamma

coactivator 1 alpha，PGC-1α)相互作用；通过ChIP方法，发现LSD1与PGC-1α共同募集到SIRT3基因的启动子区域染色质上；通过启动子活性分析，发现LSD1基因可以显著抑制PGC-1α对SIRT3基因的转录调控。结论：LSD1可以表观遗传调控抑癌基因SIRT3的转录，为深入研究LSD1与肿瘤代谢异常以及氧化应激提供了理论依据。

Abstract

Background and purpose: Lysine specific demethylase 1(LSD1) is an important chromatin modifier. It epigenetically regulates gene expression pattern through chromatin modification and participates in maintenance of tumor malignant properties

such as oncogenesis

development

invasion

migration and metabolic transformation. SIRT3 (sirtuin 3) is a mitochondria localized tumor suppressor and regulates tumor metabolic transformation and oxidative stress. The correlation between LSD1 and SIRT3 has never been reported before. This study aimed to elucidate the correlation between LSD1 and SIRT3 with gene transcriptional regulation methods. Methods: RNA interference technique

co-immunoprecipitation assay(CoIP)

chromatin immune-precipitation assay(ChIP) and firefly luciferase activity assay were employed to elucidate the correlation between LSD1 and SIRT3 in pancreatic cancer. Results: mRNA and protein levels of SIRT3 were significantly elevated in LSD1 knock-down PANC-1 cells. LSD1 interacts with PGC-1α

an important regulator of SIRT3 gene expression. LSD1 and PGC-1α occupied the same region in SIRT3 promoter region through ChIP analysis. Luciferase activity assay validated LSD1 as a negative regulator of PGC-1α in SIRT3 gene transcriptional regulation. Conclusion: LSD1

as an important tumor promoter

negatively regulates the expression of tumor suppressor gene SIRT3

these results provide important clues for the role that LSD1 plays in aberrant metabolism and oxidative stress.

关键词

Keywords

references

Views

2215

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

A research on the mechanism of SERPINA3 promoting malignant progression and gemcitabine resistance of pancreatic cancer by inhibiting ferroptosis

Effect of liposome binding antisense oligonucleotide BP1003 on albumin-bound paclitaxel sensitivity in pancreatic cancer cells by inhibiting STAT3

New advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2024

An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer

Research on uPAR promoting proliferation, migration, and chemoresistance of pancreatic cancer by inhibiting autophagy via MAPK signaling

Related Author

Yuan HE

Juncheng GUO

Zhibin YE

Xiaohu WANG

Haonan LI

Jingbiao HUANG

Hua FU

Guochao ZHOU

Related Institution

Department of Gastrointestial Surgery, Hebei General Hospital

Department of Gastrointestial Surgery, Heping Hospital Affiliated to Changzhi Medical College

The First Clinical College of Changzhi Medical College

Department of Hepatology and Gallbladder, Xiangxi Autonomous Prefecture People’s Hospital, Xiangxi

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai Pancreatic Cancer Institute, Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Pancreatic Cancer Institute, Fudan University

AI问答

⁰